Volume 3, Issue 1 (Journal of Clinical and Basic Research(JCBR) 2019)
jcbr 2019, 3(1): 29-33 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hoseini H. Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus in Patients with Thalassemia Major in Zahedan, Southeast of Iran. jcbr 2019; 3 (1) :29-33
URL: http://jcbr.goums.ac.ir/article-1-196-en.html
URL: http://jcbr.goums.ac.ir/article-1-196-en.html
Department of Laboratory Sciences, Zahedan Branch, Islamic Azad University, Zahedan, Iran
Abstract: (3751 Views)
Background and objectives: Patients with thalassemia are at high risk of hepatitis B, hepatitis C, HIV infections because of the frequent and long-term need for blood transfusion. In the present study, we aimed to determine prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV in patients with thalassemia major in a hospital in Zahedan, Iran.
Methods: This descriptive study was performed on 289 thalassemia major patients (130 men and 159 women) who were referred to the Ali ibn Abi Talib hospital in Zahedan, Southeast of Iran. First, serum of patients was checked for presence of antibodies against HB surface antigen, HCV and HIV by ELISA, and then results were confirmed by immunoblotting. Data were analyzed with SPSS 21 software using chi-square test.
Results: Of the 289 patients, 11(3.8%) were anti-HBs positive, 11(3.8%) were anti-HCV positive, and none were positive for HIV antibodies. There was no significant difference in the prevalence of the viruses between different age groups. We found no significant correlation between history of HBV vaccination and the absence of infection with the virus in thalassemia patients.
Conclusion: Although the prevalence of HCV and HBV infection is not alarmingly high in thalassemia patients in Zahedan (Southeast of Iran), screening of blood donors using more sensitive detection techniques can effectively reduce the prevalence and incidence of these viral infections in this area.
Methods: This descriptive study was performed on 289 thalassemia major patients (130 men and 159 women) who were referred to the Ali ibn Abi Talib hospital in Zahedan, Southeast of Iran. First, serum of patients was checked for presence of antibodies against HB surface antigen, HCV and HIV by ELISA, and then results were confirmed by immunoblotting. Data were analyzed with SPSS 21 software using chi-square test.
Results: Of the 289 patients, 11(3.8%) were anti-HBs positive, 11(3.8%) were anti-HCV positive, and none were positive for HIV antibodies. There was no significant difference in the prevalence of the viruses between different age groups. We found no significant correlation between history of HBV vaccination and the absence of infection with the virus in thalassemia patients.
Conclusion: Although the prevalence of HCV and HBV infection is not alarmingly high in thalassemia patients in Zahedan (Southeast of Iran), screening of blood donors using more sensitive detection techniques can effectively reduce the prevalence and incidence of these viral infections in this area.
Article Type: Research |
Subject:
Microbiology
References
1. Galanello R, Origa R. Beta-thalassemia: Orphanet J Rare Dis. Journal of Continuing Education Topics & Issues. 2012;14(1):33-4. [Google Scholar]
2. Din G, Malik S, Ali I, Ahmed S, Dasti JI. Prevalence of hepatitis C virus infection among thalassemia patients: a perspective from a multi-ethnic population of Pakistan. Asian Pacific journal of tropical medicine. 2014;7: 127-S33. [DOI] [Google Scholar]
3. Javadzadeh SH, Attar M, Yavari M, Savabieh S. Study of the prevalence of Hepatitis B, C and HIV infection in Hemophilia and Thalassemia population of Yazd. 2006:31(2).90-95. [Google Scholar]
4. Mirmomen S, Alavian S-M, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi M-J, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9(4):319-23. [Google Scholar]
5. Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran. International journal of preventive medicine. 2012;3.118. [Google Scholar]
6. Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9. [DOI]
7. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion‐transmitted infections among multitransfused patients in Iran: a review. Transfusion Medicine. 2007;17(6):425-33. [DOI] [Google Scholar]
8. Jang T-Y, Lin P-C, Huang C-I, Liao Y-M, Yeh M-L, Zeng Y-S, et al. Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients. PLoS One. 2017;12(6):83-87. [DOI] [Google Scholar]
9. Al-Mahroos FT, Ebrahim A. Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias. Annals of tropical paediatrics. 1995;15(2):121-8. [DOI] [Google Scholar]
10. Karimi M, Ghavanini A. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. Journal of paediatrics and child health. 2001;37(6):564-6. [DOI]
11. Alavian S, Tabatabaei S, Lankarani K. Epidemiology of HCV infection among thalassemia patients in eastern Mediterranean countries: a quantitative review of literature. Iranian Red Crescent Medical Journal. 2010;12(4):365. [Google Scholar]
12. Jamal R , Fadzillah G, Zulkifli SZ. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. The Southeast Asian. 1998:13(3):14-20 [Google Scholar]
13. Khan WA , Banu B, Amin SK, Selimuzzaman M . Prevalence of beta thalassemia trait and Hb E trait in Bangladeshi school children and health burden of thalassemia in our population. DS (Child) H J. 2005; 21 (1) : 1-7 [Google Scholar]
14. Elisabetta F, Barbara B, Maria Giulia M. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol. 2012 .27; 4(3): 74-80. [DOI] [Google Scholar]
15. Mohamoud YA, Riome S, Abu-Raddad LJ. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. International Journal of Infectious Diseases. 2016;46:116-25. [DOI] [Google Scholar]
16. Averhoff M, Glass N, Holtzman D. Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States. Clinical Infectious Diseases. 2012: 55(1):10-15 [DOI] [Google Scholar]
17. Shah N, Mishra A, Chauhan D, Vora C, Shah N. Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India. Asian journal of transfusion science. 2010;4(2):94-98. [DOI] [Google Scholar]
18. Hoz F De la, Muñoz MM, Jaramillo S, Estrada C. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. Journal of Clinical Virology. 2005: 34(2).33-38 [DOI] [Google Scholar]
19. Shahjalal H. Thalassemic Children in Bangladesh. Journal Medical Science .2007:7(1).131-135 [Google Scholar]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).